Skip to main content
Media Coverage

Enveric, MindBio partner to advance psilocin prodrugs for mental health disorders [Healio]

By May 21, 2024May 22nd, 2024No Comments

Enveric Biosciences announced it has signed a nonbinding term sheet to out-license a class of novel psilocin prodrugs to MindBio Therapeutics, an agreement that could yield more than $66 million in sales.

Full Article >>